This inventor holds 1 USPTO granted patent. Top assignee: Flx Discoveries Oy. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Jorma Palvimo: Innovator in Androgen Receptor Modulation
Introduction
Jorma Palvimo is a notable inventor based in Kuopio, Finland. He has made significant contributions to the field of pharmacology, particularly in the development of non-steroidal compounds that act as androgen receptor modulators. His innovative work has the potential to impact various therapeutic areas.
Latest Patents
Palvimo holds a patent for "Non-steroidal compounds as androgen receptor modulators." This invention relates to novel 4,5-dihydroisoxazoles and 4,5-dihydro[1,2,4]-oxadiazoles of formula (I). These compounds are designed for use as androgenic or antiandrogenic agents or androgen receptor modulators. The patent also includes methods for their preparation, showcasing his expertise in medicinal chemistry.
Career Highlights
Jorma Palvimo is associated with Flx Discoveries Oy, where he continues to advance his research and development efforts. His work in the company reflects his commitment to innovation in the pharmaceutical industry. With a focus on creating effective therapeutic agents, Palvimo has established himself as a key figure in his field.
Collaborations
Palvimo collaborates with talented individuals such as Tuomas Oravilahti and Mikael Perakyla. These partnerships enhance the research environment and foster the development of groundbreaking solutions in pharmacology.
Conclusion
Jorma Palvimo's contributions to the field of androgen receptor modulation exemplify the importance of innovation in medicine. His patent and ongoing work at Flx Discoveries Oy highlight his role as a leading inventor in this specialized area.